Category: Alzheimer's Disease
Global Alzheimer's Disease
-
2022 Global Forecast for Alzheimer'S Disease Diagnostic Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis, Drug Discovery and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028
... and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028 Global Brain Biomarkers Market is valued approximately USD XX million in 2021 and is anticipated to grow ... Read More
-
Alzheimer’s Drugs Market Size and Share - Global Forecast, 2022 - 2028
... encounters various behavioral change with dementia, as a primary symptoms, which gets worse as disease progress. It majorly affects people of age group 65 and above. Currently, there is no therapeutic cure available for Alzheimer’s ... Read More
-
Wearable Brain Devices Market Size, Share & Trends Analysis Report By Channel Type (32-Channel Type, 12-Channel Type), By Application (Medical Setting, AR/VR Gaming Settings), By End User, By Region, And Segment Forecasts, 2022 - 2030
... Wearable Brain Devices Market Growth & Trends The global wearable brain devices market size is anticipated to reach USD 668.5 million by 2030, registering a CAGR of 12.33%, according to a new report by Grand ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Global Lewy Body Dementia Treatment Market Size study, by Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, Modafinil) by Application Type (Parkinson’s Disease, Alzheimer’s Disease) by Mode of Purchase (Prescription and Over the Counter) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2022-2028 Global Lewy Body Dementia Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a ... Read More
-
Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA) and Others), by Route of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028
... of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028 Global Johnson Neuroectodermal Syndrome Market is valued approximately USD XX billion in 2022 and is anticipated ... Read More
-
Brain Disease Modalities and Software Market - A Global and Regional Analysis: Focus on Product, Indication, Patient Type, End User, and Regional Analysis - Analysis and Forecast, 2022-2031
... and Software Market Segmentation Indication - Brain Diseases (Brain and Central Nervous System Cancer, Idiopathic Epilepsy, Ischemic stroke, and Other Brain Diseases) and Neurodegenerative Diseases (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, Motor Neuron Disease, and ... Read More
-
Global Alzheimer Drugs Market (2022 Edition) – Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By Region, By Country: Market Insights, Pipeline and Forecast with Impact of Covid-19 (2022-2027)
... to Azoth Analytics research report, the Global Alzheimer's Drugs Market was valued at USD 6537.0 Million in the year 2021. Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy ... Read More
-
Global Alzheimer's Disease Market and Competitive Landscape – 2017
... sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Alzheimer's Disease market size and drug sales. This research also provides insights into Alzheimer's Disease epidemiology and late stage pipeline. The ... Read More
Research Assistance
